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Summary
 
CD45-AP specifically associates with CD45, a protein tyrosine phosphatase essential for lym-
phocyte differentiation and antigen receptor–mediated signal transduction. CD45 is thought to
mediate antigen receptor signaling by dephosphorylating regulatory tyrosine residues on Src
family protein tyrosine kinases such as Lck. However, the mechanism for regulating CD45
protein tyrosine phosphatase activity remains unclear. CD45-AP–null mice were created to ex-
amine the role of CD45-AP in CD45-mediated signal transduction. T and B lymphocytes
showed reduced proliferation in response to antigen receptor stimulation. Both mixed leuko-
cyte reaction and cytotoxic T lymphocyte functions of T cells were also markedly decreased in
CD45-AP–null mice. Interestingly, the interaction between CD45 and Lck was significantly
reduced in CD45-AP–null T cells, indicating that CD45-AP directly or indirectly mediates the
interaction of CD45 with Lck.
 
 
 
Our data indicate that CD45-AP is required for normal antigen
receptor signaling and function in lymphocytes.
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T
 
he earliest stages of lymphocyte antigen receptor sig-
naling are mediated by protein tyrosine kinases (PTKs)
 
1
 
that are associated with the receptor complexes (1). The
cytoplasmic segments of lymphocyte antigen receptors and
their coreceptors recruit Src and Syk family PTKs by form-
ing specific associations. There is increasing evidence that
the activities of these PTKs are regulated by several different
mechanisms, including alterations in the phosphorylation
status of their key tyrosyl residues and interactions with
other molecules. The intracellular domain of CD45 exhibits
protein tyrosine phosphatase (PTP) activity and is essential
for antigen receptor–mediated signal transduction in lym-
phocytes (2). It has been proposed that CD45 activates Src
family PTKs such as Lck in T cells by dephosphorylating
their downregulatory tyrosyl residues (3, 4). The essential
role of CD45 in antigen receptor signaling was demon-
strated when reconstitution of the cytoplasmic domain of
CD45 in CD45-negative lymphocytes restored the ability
of these cells to transduce antigen receptor–mediated stim-
ulatory signals (5–7).
One of the central questions in signal transduction is
how specificity is preserved among various interacting mol-
ecules in signaling cascades. In this respect, it remains un-
clear how CD45 PTP targets particular substrates and leads
to amplification of specific stimulatory signals rather than
indiscriminately dephosphorylating various tyrosine phos-
phorylated proteins, resulting in downregulation of the sig-
nal. Most of the CD45 in lymphocytes exists in a complex
with a lymphocyte-specific protein, CD45-AP (associated
protein; 8–10). The transmembrane segment of CD45-AP
binds specifically to the transmembrane segment of CD45
(11–13). The role of CD45-AP has remained unknown,
but it has been hypothesized that CD45-AP plays an
adapter-like role for CD45, coordinating its interactions
with molecules involved in signal transduction. We created
CD45-AP–null mice by homologous recombination in or-
der to examine the role of CD45-AP in CD45-mediated
lymphocyte signal transduction. Unlike CD45-deficient
(14) or -null mice (15), lymphocytes developed normally in
CD45-AP–null mice. However, deletion of CD45-AP re-
sulted in impaired T and B cell responses to antigen recep-
tor stimulation. Defects in both proliferation and functional
capacity were observed. In addition, T cells showed a re-
duced response to stimulation with a combination of PMA
and ionomycin. The interaction between CD45 and Lck
was significantly reduced in CD45-AP–null cells. These
 
1
 
Abbreviations used in this paper:
 
 AP, associated protein; ES, embryonic
stem; PKC, protein kinase C; PTK, protein tyrosine kinase; PTP, protein
tyrosine phosphatase.
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data indicate that CD45-AP is required for a normal inter-
action between CD45 and Lck and that this interaction in
turn is required for normal signal transduction in T lym-
phocytes.
 
Materials and Methods
 
Creation of CD45-AP–null Mice.
 
A targeting DNA construct
was prepared by ligating two segments, of 3 kb and 1.6 kb, of the
genomic clone (10) and an 
 
HSV-tk
 
 gene cassette (obtained from
H. Westphal, National Institute of Child Health and Human De-
velopment, Bethesda, MD) into pMC1neo poly(A) vector (Strat-
agene, La Jolla, CA). The 625-bp KpnI-NsiI genomic fragment
that contains all the coding region of the unspliced form of
CD45-AP (9) and all but the first five amino acid sequences of
the spliced form of CD45-AP (16) was replaced by the 
 
neo
 
 (neo-
mycin resistance) gene cassette. RW4 embryonic stem (ES) cells
(Genome Systems, St. Louis, MO) were transfected by electropo-
ration with the targeting construct linearized by SalI, and colonies
resistant to G418 and gancyclovir were screened for homologous
recombination by genomic Southern hybridization with a probe
that is immediately 3
 
9
 
 to the 1.6-kb genomic sequence. NsiI di-
gestion of genomic DNA obtained from normal mice or from ES
cells without homologous recombination results in a 6.1-kb frag-
ment on Southern hybridization. 4 ES colonies out of 216 exhib-
ited an altered Southern hybridization pattern as a result of ho-
mologous recombination. These clones were injected into blastocysts
of C57BL/6 mice and chimeric mice were produced. Two out of
five male chimeras had germline transmission of the mutant
CD45-AP allele and mice heterozygous for the CD45-AP dele-
tion were identified among their offspring. Homozygous mice
were then bred by crossing the heterozygotes and identified by
Southern hybridization of genomic DNA.
 
CD45 PTP Activity Assay.
 
CD45 was isolated from equal num-
bers of cells obtained from thymus or spleen of 7–9-wk-old CD45-
AP–null mice or age-matched wild-type counterparts by immu-
noprecipitation. CD45 was eluted by briefly subjecting the
immunoprecipitates to high pH in 50 mM of diethanolamine (8).
A portion of the CD45 preparation was used for PTP activity as-
say with Raytide (Oncogene Research Products, Cambridge,
MA) as a substrate and another portion was analyzed by immuno-
blotting with anti-CD45 antibody (provided by J. Marth, Univer-
sity of California San Diego, La Jolla, CA). The substrate for PTP as-
say was prepared by labeling Raytide with 
 
g
 
-[
 
32
 
P]ATP and Src
PTK (Oncogene Research Products). PTP activity was deter-
mined by measuring the release of 
 
32
 
PO
 
4
 
 from the labeled Raytide as
previously described (8). The amount of CD45 in the samples
was determined by densitometric analysis of the immunoblots.
 
Proliferation and Function Assays of T and B Lymphocytes.
 
Splenic
T and B cells of 7–9-wk-old CD45-AP–null mice or wild-type
littermates were purified by a combination of one round of ny-
lon-wool fiber column followed by negative selection with anti-
body-mediated affinity columns (Biotex Laboratories, Edmonton,
Alberta, Canada). Typical T and B cell populations thus obtained
were 90 and 95% pure, respectively, by flow cytometric analysis
of surface markers. T cells were stimulated by plate-bound (at
5 
 
m
 
g/ml) anti–TCR-
 
a/b
 
 Ab (PharMingen, San Diego, CA; ref-
erence 17), Con A (2 
 
m
 
g/ml), or a combination of PMA (10 ng/ml)
and ionomycin (400 ng/ml). B cells were stimulated by F(ab
 
9
 
)
 
2
 
fragment of anti-IgM Ab (10 
 
m
 
g/ml; Jackson Immunoresearch
Labs., West Grove, PA), anti-CD40 Ab (5 
 
m
 
g/ml; Serotec, Wash-
ington DC) (18), LPS (4 
 
m
 
g/ml), or a combination of PMA (10
ng/ml) and ionomycin (400 ng/ml). For some assays mitomycin
C-treated spleen cells of wild-type mice were added to purified T
cells as a source of accessory cells. Cell proliferation was deter-
mined after 72 h by measuring [
 
3
 
H]thymidine incorporation
(pulsed at 1 
 
m
 
Ci/well overnight) into cells incubated at 10
 
5
 
 cells
per well in 200 
 
m
 
l DMEM with 10% FCS. For MLR, splenic T
cells (MHC H-2
 
b
 
 haplotype) (4 
 
3 
 
10
 
6
 
 cells/ml) were cultured
with mitomycin C–treated spleen cells (4 
 
3 
 
10
 
6
 
 cells/ml) derived
from MHC-incompatible BALB/c (MHC H-2
 
d
 
 haplotype) or
MHC-compatible C57BL/6 mice (MHC H-2
 
b
 
 haplotype) for 4 d
before overnight [
 
3
 
H]thymidine pulse. CTLs were generated
from spleen cells (MHC H-2
 
b
 
 haplotype) (5 
 
3 
 
10
 
6
 
 cells/ml) by
coculturing with mitomycin C–treated spleen cells (3 
 
3 
 
10
 
6
 
 cells/
ml) derived from MHC-incompatible BALB/c mice (MHC H-2
 
d
 
haplotype) in the presence of conditioned medium Rat T-STIM
(Collaborative Biomedical Products, Bedford, MA) for 5 d. Non-
adherent CTLs were then harvested and used as effector cells.
Cells of H-2
 
d
 
 haplotype (T cell line S49.1) or H-2
 
b
 
 haplotype
(spleen cells of C57BL/6 mice) were labeled with 
 
51
 
Cr and used
as targets for CTL in a radioactive chromium release assay.
 
Determination of Interaction between CD45 and Lck.
 
Splenic T cells
from 7–9-wk-old CD45-AP–null mice or age-matched wild-type
counterparts were purified by two successive rounds of nylon-
wool fiber columns. The typical T cell population thus obtained
was 85% pure by flow cytometric analysis of surface markers.
T cells, 4
 
 3 
 
10
 
7
 
 cells/ml in IMDM, were incubated first with
anti–TCR-
 
a/b
 
 Ab (10 
 
m
 
g/ml; PharMingen; reference 17) on ice
for 3 min followed by the addition of anti–hamster IgG (12.5 
 
m
 
g/
ml) and further incubation at 37
 
8
 
C for 0, 5, 10, or 60 min for
stimulation. After two washes in cold IMDM, the cells were lysed
at 5 
 
3 
 
10
 
7
 
 cells/ml in 0.8% polyoxyethylene 10 oleyl ether (BRIJ
96) containing 50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1 mM
MgCl
 
2
 
, 0.1 mM EGTA, 2.5 mM thioglycolic acid, 1 mM PMSF,
10 mM sodium fluoride, 1 mM sodium orthovanadate, and 10 mM
pyrophosphate. Postnuclear supernatants of the lysates were first
precleared with Protein G–Sepharose 4 beads (Pharmacia Bio-
tech, Piscataway, NJ) and were then immunoprecipitated either
with anti-CD45 Ab (19) cross-linked to Protein G–Sepharose 4
beads with dimethyl pimelimidate (20) or with unconjugated
Protein G–Sepharose 4 beads. Material bound to the beads was
analyzed by immunoblotting with Abs against CD45 (provided
by J. Marth) and Lck (Zymed Labs., South San Francisco, CA)
followed by horseradish peroxidase–conjugated Protein A or
anti–mouse Ig and the Supersignal substrate system (Pierce,
Rockford, IL).
 
Results and Discussion
 
Creation of CD45-AP–null Mice.
 
There are two forms
of CD45-AP mRNA with a minor difference at the NH
 
2
 
terminus as a result of splicing (9, 10, 16). The two result-
ing CD45-AP proteins are identical in their capacity for
specific binding to CD45, but use different mechanisms for
endoplasmic reticulum membrane translocation (10). The
genomic DNA segment that encodes the entire coding re-
gion of the first form of CD45-AP and all but the first five
amino acids of the second form was replaced with the 
 
neo
 
gene cassette by homologous recombination in ES cells
(Fig. 1 
 
A
 
). NsiI digestion of genomic DNA obtained from
normal mice or from ES cells without homologous recom-
bination results in a 6.1-kb fragment on Southern hybrid- 
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ization. ES colonies that exhibited an altered Southern hy-
bridization pattern as a result of homologous recombination
were injected into blastocysts of C57BL/6 mice. Mice het-
erozygous and homozygous for the CD45-AP deletion
were identified by Southern blot analysis of genomic DNA
(Fig. 1 
 
B
 
). No CD45-AP protein was detected in cell ly-
sates of spleen cells and thymocytes obtained from the ho-
mozygous mutants by immunoblot analysis with antiserum
against CD45-AP (11), confirming that these homozygous
mice are indeed CD45-AP–null (Fig. 1 
 
C
 
).
 
Normal Lymphocyte Development but Reduced CD45 Ex-
pression in CD45-AP–null Mice.
 
Gross morphological and
histological analysis of all organ systems of CD45-AP–null
mice did not show any abnormality, nor did flow cytomet-
ric analysis of cells obtained from thymus, spleen, lymph
nodes, bone marrow, and peritoneal cavity. Therefore, leu-
kocytes appeared to differentiate normally in these mice
unlike in CD45-deficient (14) or -null mice (15). However,
the surface expression of CD45 measured by flow cytome-
try was reduced in the mutant mice compared with their
wild-type littermates (Fig. 2 
 
A
 
). The average fluorescence
intensities of thymocytes and spleen cells obtained from
CD45-AP–null mice were 86.2% (
 
6 
 
6.7% SD; 4 experi-
ments) and 73.9% (
 
6 
 
2.4% SD; 6 experiments), respec-
tively, of wild-type littermates. Expression of all isotypes of
CD45 appeared reduced since the average fluorescence in-
tensities of CD45-AP–null spleen cells stained with Abs
against CD45RA (clone 14.8, PharMingen), CD45RB
(clone 16A, PharMingen), and CD45RC (clone DNL-1.9,
PharMingen) were 71.8% (
 
6 
 
5.3% SD; 4 experiments),
75.6% (
 
6 
 
2.5% SD; 4 experiments), and 79.7% (
 
6 
 
14.6%
SD; 5 experiments), respectively, of wild-type cells. Inter-
estingly, a subset of thymocytes that expresses high levels of
CD45, seen as a second peak in the thymic CD45 profile of
 
1
 
/
 
1
 
 mice (Fig. 2 
 
A
 
), was absent in CD45-AP–null mice.
Thymocyte subpopulations known to express high levels of
CD45 are mature CD4
 
1
 
 or CD8
 
1
 
 single-positive cells and
large, cycling, positively selected CD4
 
1
 
CD8
 
1
 
 cells (21).
Purified splenic T and B cells of CD45-AP–null mice ex-
hibited equally reduced levels of CD45 expression, i.e.,
73.5% (
 
6 
 
2.5% SD; 5 experiments) and 73.2% (
 
6 
 
1.8%
SD; 4 experiments) average fluorescence intensities, respec-
tively, of wild-type controls.
To determine whether the reduction in surface CD45
correlates with a reduction in total cellular CD45, the
amount of total cellular CD45 in thymocytes and spleen
cells was measured by immunoblotting of total cell lysates
with anti-CD45 antisera (Fig. 2 
 
B
 
) followed by densito-
metric analysis. Total CD45 in thymus and spleen was re-
duced to 56.7% (
 
6 
 
12.5% SD; 5 experiments) and 69.8%
(
 
6 
 
9.3% SD; 4 experiments), respectively, of wild-type
counterparts. Thus, the amount of total CD45 in thy-
mocytes is disproportionately small compared with the sur-
face level detected by flow cytometry, whereas the total
amount in spleen corresponds to the surface expression
level. These results indicate that the thymocytes of CD45-
AP–null mice contain a much smaller amount of intracellu-
lar CD45 compared with wild-type thymocytes and sug-
gest the intriguing possibility that CD45-AP affects the
subcellular localization of CD45 differentially in thy-
mocytes and spleen cells.
The reduced expression of CD45 in CD45-AP–null cells
suggests that CD45 is unstable in the absence of its binding
partner, CD45-AP. Likewise, it has been reported that
CD45-AP protein levels were much lower in three out of
four CD45-negative T cell lines compared with their
CD45-positive wild-type parental lymphocytes, suggesting
that CD45-AP is unstable in the absence of CD45 (10).
 
Normal CD45 PTP Activity in CD45-AP–null Mice.
 
Amino acid sequence analysis and protease susceptibility
Figure 1. CD45-AP gene tar-
geting. (A) A targeting DNA
construct for homologous re-
combination in ES cells is shown
in comparison to the wild-type
and the mutant alleles. In the tar-
geting construct, the neo gene
that replaces the CD45-AP gene
is flanked by a 3-kb and 1.6-kb
genomic sequences, and the her-
pes simplex virus thymidine kinase (HSV-tk) gene cassette is ligated to the
3-kb genomic fragment. NsiI digestion of wild-type genomic DNA re-
sults in a 6.1-kb fragment by Southern hybridization with a probe that is
immediately 39 to the 1.6-kb genomic sequence. In the mutated allele,
the fragment is larger than 12 kb. (B) Southern hybridization of genomic
DNA obtained from tails of wild type (1/1), homozygous (2/2), and
heterozygous (1/2) littermates for the mutated allele. The DNA was di-
gested with NsiI and probed with the segment shown in A. (C) Cell ly-
sates were prepared from equal numbers of cells obtained from thymus
and spleen of wild-type (1/1) and homozygous (2/2) littermates for
the mutated allele and were analyzed by immunoblotting with anti–
CD45-AP antisera. 
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analysis of CD45-AP indicate that only a short segment at
the NH
 
2
 
 terminus of CD45-AP is located extracellularly,
with the bulk of the protein being intracellular (11).
CD45-AP and CD45 form a specific association through
their respective transmembrane segments (11–13), whereas
the two PTP domains of CD45 reside intracellularly (2).
Therefore, it seems unlikely that binding of CD45-AP di-
rectly affects CD45 PTP activity since the binding does not
involve the PTP domains. In fact, the PTP activity of
CD45 isolated from a T cell line, YAC-1, was not altered
by binding to recombinant CD45-AP in vitro (Takeda, A.,
unpublished observations). However, the possibility re-
mains that CD45-AP coordinates the interaction between
CD45 and other regulatory molecules and thus affects its
PTP activity indirectly. Therefore, PTP activities of CD45
isolated from thymus and spleen of CD45-AP–null mice
were compared with their wild-type counterparts by mea-
suring the release of 
 
32
 
PO
 
4
 
 from 
 
32
 
P-labeled Raytide. The
amount of CD45 was estimated by immunoblotting of the
CD45 samples with anti-CD45 antisera followed by densi-
tometric analysis of the immunoblots. Specific activities of
CD45 PTP were obtained by dividing CD45 PTP activity
by the amount of CD45. As shown in Table 1, the deletion
of CD45-AP did not affect CD45 PTP activity in either
thymus or spleen.
 
Reduced Proliferation and Function of T and B Lymphocytes of
CD45-AP–null Mice in Response to Antigen Receptor Stimula-
tion.
 
In vitro analysis of proliferative responses of splenic
T and B cells to various stimuli revealed interesting differ-
ences between CD45-AP–null mice and their wild-type
littermates. Proliferative responses of CD45-AP–null T
cells to TCR-mediated stimuli were significantly reduced
regardless of the presence or absence of accessory cells (
 
AC
 
;
Fig. 3 A). Strikingly, the response of CD45-AP–null T
cells to a combination of PMA and ionomycin was reduced
to ,50% of wild-type whereas the response to Con A was
comparable to that of the control. The proliferative re-
sponse of mutant B cells to anti-IgM Ab was reduced to
half of the wild-type, whereas their responses to anti-CD40
Ab, LPS, or a combination of PMA and ionomycin were
comparable to control levels (Fig. 3 B).
No difference in fluorescence intensity was observed be-
tween CD45-AP–null and wild-type littermates when their
spleen cells were stained with FITC-labeled anti–TCR-a/b
(clone H57-597; PharMingen) or anti-IgM (clone R6-
60.2; PharMingen) Ab and analyzed by flow cytometry
(data not shown). Therefore, the reduced proliferative re-
sponses of CD45-AP–null lymphocytes to antigen receptor
ligation are due to defects in signal transduction and not
differences in receptor numbers. Furthermore, cells ob-
tained by two successive rounds of nylon-wool fiber col-
umns gave identical results in the proliferation assays to
those obtained by negative selection with antibody-medi-
ated affinity columns (data not shown). Thus, incubation of
cells with antibodies during the cell purification procedures
had no effect on the outcome of the cell proliferation and
function assays.
B cells of both CD45-deficient and CD45-null mice dif-
ferentiate normally but fail to proliferate in response to
anti-IgM stimulation (14, 15). The mechanism by which
Figure 2. Expression of CD45 in CD45-AP–null mice. (A) Thymus and spleen cells obtained from CD45-AP–null (2/2) and wild-type (1/1) litter-
mates were stained with FITC-conjugated anti-CD45 antibody (clone 30-F11; PharMingen). A representative flow cytometric analysis is shown. (B) Cell
lysates were prepared from equal numbers of cells obtained from thymus and spleen of CD45-AP–null (2/2) and wild-type (1/1) littermates and were
analyzed by immunoblotting with anti-CD45 antisera. A representative immunoblot is shown.
Table 1. Relative Specific Activity of CD45 PTP
Origin of cells
Specific activity (arbitrary units)
1/12 / 2
Thymus 28.1 6 0.63 29.1 6 1.58
Spleen 14.1 6 0.26 14.4 6 0.89
CD45 was isolated from equal numbers of cells obtained from thymus
and spleen of CD45-AP–null (2/2) or wild-type (1/1) mice. A por-
tion of the CD45 preparation was used for PTP activity assay with Ray-
tide as a substrate and another portion was analyzed by immunoblotting
with anti-CD45 Ab. Specific activity (arbitrary units) was obtained by
dividing PTP activity by the amount of CD45. Data are expressed as an
arithmetic mean 6 SD.1867 Matsuda et al.
the absence of CD45 leads to failed proliferation is un-
known. Thus, it is possible that the reduced B cell response
to anti-IgM stimulation observed in CD45-AP–null mice
(Fig. 3 B) is due to the decreased expression of CD45 in
CD45-AP–null B cells. On the other hand, there is a con-
siderable amount of evidence that CD45 plays a similar role
in antigen receptor–mediated signal transduction of T and
B cells, namely, by dephosphorylating regulatory tyrosine
residues of their respective Src family PTKs (1, 2). As de-
scribed below (Fig. 4 B), the interaction of CD45 with Lck
in T cells is significantly decreased in CD45-AP–null mice.
Therefore, it is also possible that the reduced B cell re-
sponse to anti-IgM stimulation observed in CD45-AP–null
mice is a result of a reduced interaction of CD45 with B
cell PTKs.
As expected from the impaired proliferative response of
CD45-AP–null T cells to anti-TCR antibodies, spleen cells
of CD45-AP–null mice exhibited reduced responses in
MLR and CTL assays. CD45-AP–null T cells showed a
markedly reduced proliferative response in MLR when
they were cultured with mitomycin C–treated allogeneic
lymphocytes obtained from BALB/c mice (Fig. 3 C). Syn-
Figure 3. CD45-AP–null T and B cell responses to various stimuli. (A) Splenic T cells obtained from CD45-AP–null mice (2/2, hatched bars) or their
wild-type littermates (1/1, filled bars) were stimulated by plate-bound anti–TCR-a/b Ab, Con A, or a combination of PMA and ionomycin. Some as-
says included accessory cells (AC). Cell proliferation was determined by measuring [3H]thymidine incorporation. Representative results of five experi-
ments are shown. (B) Splenic B cells obtained from CD45-AP–null (2/2, hatched bars) or wild-type (1/1, filled bars) littermates were stimulated by
F(ab9)2 fragment of anti-IgM Ab, anti-CD40 Ab, LPS, or a combination of PMA and ionomycin. Cell proliferation was determined by measuring
[3H]thymidine incorporation. Representative results of five experiments are shown. (C) For MLR, splenic T cells obtained from CD45-AP–null (2/2,
hatched bars) or wild-type (1/1, filled bars) littermates were cocultured with mitomycin C–treated spleen cells derived from either MHC-incompatible
(H-2d haplotype) BALB/c or MHC-compatible (H-2b haplotype) C57BL/6 mice for 4 d before [3H]thymidine pulse. Representative results of three ex-
periments are shown. (D) CTLs were generated from spleen cells of CD45-AP–null mice (2/2) or wild-type littermates (1/1) by coculturing with mi-
tomycin C–treated spleen cells derived from MHC-incompatible (H-2d haplotype) BALB/c mice for 5 d. 51Cr-labeled MHC-incompatible (H-2d haplo-
type) S49.1 cells (circles) were used as targets and percentage of cell lysis was measured by 51Cr-release. 51Cr-labeled MHC-compatible (H-2b haplotype)
C57BL/6 spleen cells (triangles) were similarly used as a negative control. Representative results of three experiments are shown.1868 Role of CD45-AP in CD45-mediated Signaling
geneic lymphocytes obtained from C57BL/6 mice did not
trigger proliferation in either mutant or wild-type T cells.
An z50% decrease in CTL activity against MHC-incom-
patible S49.1 cells was observed in spleen cells derived from
CD45-AP–null mice compared with their wild-type litter-
mates (Fig. 3 D). When MHC-compatible spleen cells ob-
tained from C57BL/6 mice were used as targets no signifi-
cant killing was observed with either mutant or wild-type
CTLs.
These data show that T cells of CD45-AP–null mice
failed to mount adequate responses not only with stimuli
that trigger signaling events at the membrane surface but
also with a combination of PMA and ionomycin. Stimula-
tion with a combination of PMA and ionomycin provides a
measure of cell response irrespective of upstream signaling
events by directly stimulating protein kinase(s) C (PKC) and
causing intracellular calcium influx. Since the response to a
combination of PMA and ionomycin in CD45-AP–null B
cells is unaffected, it is possible that CD45-AP has a role in
signaling events that is T cell specific and downstream of
PKC. PKC appears to have multifaceted and complex
functions in TCR signal transduction pathways (22). PKC
may function either upstream or downstream of Ras in the
Ras pathway, or parallel to the Ras pathway for enhancing
TCR signals (23, 24). Effectors of PKC in these pathways
have not been established but candidates include the Ras
GTPase-activating protein (p120-GAP), Lck, Raf-1, and
Sos (guanine nucleotide exchange factor). Studies to iden-
tify the cause of PKC-mediated signaling blockage in
CD45-AP–null mice are in progress.
Reduced Interaction between CD45 and Lck in CD45-AP–null
T Cells. Most of the CD45 population in lymphocytes
exists as a complex with CD45-AP with a stoichiometry of
1:1 (8). It has been hypothesized that CD45-AP coordi-
nates the interaction between CD45 and other molecules
involved in CD45-mediated signaling (9). Therefore, we
examined the interaction of CD45 with Lck, a Src family
PTK associated with the TCR complex and a likely CD45
substrate in vivo (3, 4). Splenic T cells of CD45-AP–null
mice and wild-type mice were stimulated by TCR ligation
with anti–TCR-a/b Ab and cell lysates were prepared at
various time points after stimulation. The total amount of
Lck present in the cell lysates was equal between the sam-
ples obtained from CD45-AP–null and wild-type cells and
also remained unchanged during the stimulation as shown
in Fig. 4 A. Material immunoprecipitated with anti-CD45
Ab or with control beads was analyzed by immunoblotting
with anti-CD45 and anti-Lck Abs (Fig. 4 B). In wild-type
mice, the amount of Lck associated with CD45 increased
after 5 and 10 min of stimulation and returned to the base-
line level after 60 min of stimulation. In contrast, in CD45-
AP–null mice the amount of Lck coimmunoprecipitating
with CD45 was significantly diminished compared with
that seen in wild-type mice and was not affected by stimu-
lation. The amounts of Lck and CD45 in immunoprecipi-
tates were quantitated by densitometry of the immunoblots
Figure 4. Interaction of CD45
with Lck in CD45-AP–null cells.
(A) Splenic T cells obtained from
CD45-AP–null (2/2) or wild-
type (1/1) mice were stimu-
lated by cross-linking of TCR-a/b
receptors. Cell lysates prepared at
various time points after stimu-
lation were analyzed by immu-
noblotting with anti-Lck Ab.
Representative results of five ex-
periments are shown. (B) Cell
lysates described in A were
immunoprecipitated with either
control Protein G beads (2) or
Protein G beads conjugated with
anti-CD45 Ab (1). The immu-
noprecipitates were analyzed by
immunoblotting with anti-CD45
antisera or anti-Lck Ab. The ra-
tios of Lck versus CD45 were
obtained by densitometric analysis
of the immunoblots. The Lck/
CD45 ratios shown are the aver-
age of five experiments. The
Lck/CD45 ratio obtained at 0 min
stimulation of wild-type cells in
each experiment was assigned a
value of 100 and all other Lck/
CD45 ratios of the same experi-
ment were normalized relative to
that value to obtain the arith-
metic means 6 SD.1869 Matsuda et al.
and Lck/CD45 ratios were obtained. The Lck/CD45 ratio
increased in wild-type cells after 5 and 10 min of stimula-
tion but remained at constantly lower levels in CD45-
AP–null cells. The Lck/CD45 ratios of wild-type T cells
were 1.9-, 2.5-, 2.7-, and 2.7-fold more than those of
CD45-AP–null T cells at stimulation times 0, 5, 10, and 60
min, respectively. The low, but detectable, levels of associ-
ation between CD45 and Lck in CD45-AP–null mice in-
dicate that CD45 is capable of associating with Lck at a
lower level in the absence of CD45-AP. In fact, direct as-
sociation has been observed between recombinant CD45
and Lck in vitro (25). However, when CD45 and Lck were
expressed in fibroblasts that do not express CD45-AP,
CD45 failed to stably dephosphorylate the kinase-active
form of Lck (26), suggesting that an CD45-AP is required
for optimally functioning association of CD45 with Lck.
Dephosphorylation of downregulatory tyrosine residues
by CD45 is thought to be required for the activity of Src
family PTKs that function early in lymphocyte signal trans-
duction (1–4). However, the PTP activity of CD45 is po-
tentially capable of counteracting the activity of PTKs by
dephosphorylating their substrates (27, 28). Given the im-
portant role of CD45 in lymphocyte differentiation and
signal transduction, there must be a mechanism in vivo that
either regulates the CD45 PTP activity itself or restricts its
access to substrates. Our results demonstrate that CD45-AP
is essential for normal interactions of CD45 with a TCR-
associated PTK, Lck, in vivo (Fig. 4). It remains to be
determined whether CD45-AP directly mediates the inter-
action between CD45 and Lck. Combined with the func-
tional impairments exhibited by T and B lymphocytes of
CD45-AP–null mice (Fig. 3), our results strongly support
the notion that CD45-AP plays an important role in coor-
dinating the interaction between CD45 and the appropri-
ate PTKs involved in CD45-mediated signal transduction.
This function of CD45-AP may provide a means for regu-
lation of CD45 PTP by targeting appropriate substrates.
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